• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Leishmaniasis Treatment Market To Reach USD 224.67 Million by 2027

March 27th, 2020 Reports And Data Releases

According to the current analysis of Reports and Data, the global Leishmaniasis Treatment market was valued at USD 114.02 million in 2019 and is expected to reach USD 224.67 million by the year 2027, at a CAGR of 8.8%. A disease outbreak takes place when a disease escalates by a higher number than expected in a region or during a season. An outbreak may occur in one community or even extend to several countries altogether. There was a time when people in all countries and on all continents remain chronically vulnerable to infectious diseases, known and unknown. Leishmaniasis was the neglected tropical disease (NTD) that has threatened the people worldwide as per the WHO.

Leishmaniasis is a major complex of protozoal vector-borne diseases that affects both humans and animals. The disease is caused by different species of Leishmania, and it is manifested by three major clinical forms named as cutaneous, mucosal, and visceral leishmaniasis. Leishmaniasis is transmitted by the bite of infected female sand flies. In each of these forms, infection ranges from causing no symptoms (asymptomatic infection) to severe, even life-threatening complications.

Request free sample Copy of this research report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/2153

According to the National Organization of Rare Disorders, only a small percentage of people infected by Leishmania parasites will go on to actually develop the disease. There is an uneven global distribution of the disease often because of the various distribution pattern of the parasite, the vector, and the reservoir host species. Efforts to increase visceral leishmaniasis surveillance, vector control, diagnosis, and treatment are making remarkable progress all across the world. In 2012, WHO launched an action plan for reducing the impact of Neglected Tropical Diseases (NTDs), including visceral leishmaniasis. Leishmaniasis is seldom encountered in the United States.

Leishmaniasis treatment market has huge untapped potential in different regions and extensive unexplored applications in the field of healthcare and therapeutics. Early case detection and treatment are the most important control measures for leishmaniasis. The treatment reduces or eliminates parasite loads, and this, in turn, reduces transmission of the parasite further. Thus surveillance and control are directly linked. Moreover, the migration pattern of the population from one place to another for purposes such as medical tourism positively supports market growth. The availability of treatment options is attracting the government’s attention to investing in it. Over a period of time, the R&D investment and funding from agencies have significantly increased. The main limitations to treatment are high cost and the relatively long treatment period. In difficult situations such as epidemics and highly endemic areas, vector control is also used. It consists of house spraying or the use of insecticide-impregnated bed nets. Treating leishmaniasis is difficult, as it depends on several factors, the existence of several parasitic forms of Leishmania, including the form of the disease, other co-existing infections, environmental conditions of different regions, the parasitic species, and geographic location. Furthermore, the overall treatment responses differ by region and hinder the widespread adoption of the treatment. Moreover, this could possibly be one of the major restraints for the leishmaniasis treatment market during the forecast period.

Further key findings from the report suggest

  • The introduction of a new chemical entity will drive the leishmaniasis treatment market. According to the data of Drugs for Neglected Diseases initiative (DNDi), in 2017, two new chemical entities, labeled DNDI-6148 and DNDI-0690, were introduced into the pre-clinical development stage to treat visceral and cutaneous leishmaniasis in 2016. Immunomodulator- CpG-D35, is also in a pre-clinical development stage, which would further be used as an adjunct along with main drug therapy to treat cutaneous leishmaniasis. These technical advances have the potential to transform new treatment therapy in the upcoming future, in turn driving the growth of the leishmaniasis treatment market during the forecast period.
  • In the pathological testing segment, serological testing is expected to be the fastest-growing segment, which is expected to grow at a CAGR of 9.4% during the forecast period due to the global rise in the infectious disease outbreaks, including include Leishmaniasis in developing nations. The outbreak of epidemic disease due to malnutrition, population displacement, poor housing, weak immune system, and lack of financial resources are responsible for the market growth across the globe.
  • Visceral Leishmaniasis holds the CAGR of 9.2%, which is highest in the disease segment of the leishmaniasis treatment market. According to the data of WHO, an estimated 50 000 to 90 000 new cases of Visceral Leishmaniasis occur worldwide each year, out of which only an estimated 25–45% are reported to WHO. In 2017, more than 95% of new cases were reported to WHO which mainly occurred in 10 countries Bangladesh, Brazil, China, Ethiopia, India, Kenya, Nepal, Somalia, South Sudan, and Sudan
  • Europe is the second-largest regional segment with the market share of over 28.4% in 2019, due to the increased awareness of the availability of different therapies and drugs for the treatment and rising awareness about innovations and advancements in Leishmaniasis treatment in pharmaceutical molecules, coupled with rising incidences of target diseases across the world
  • North America is expected to account for the largest market share of 2% of the Leishmaniasis treatment market, owing to the prevalence of unhealthy lifestyle, high number of target diseases, rise in the number of product approval by FDA, ongoing clinical trials, and favorable government regulations scenario contributing to the development of healthcare and therapeutics
  • Visceral Leishmaniasis is expected to have the largest market share of 46.8% during the forecast period. According to the WHO, Visceral leishmaniasis (VL) is the world’s second-deadliest parasitic disease after malaria. Key market players are collaborating with several government and private agencies to rise for the cause. For instance, Gilead is donating 445,000 vials of AmBisome to the World Health Organization over five years, which is a leading brand in the treatment of leishmaniasis.
  • Key participants in the market are Sanofi S.A., Sequus Pharmaceuticals Inc., Paladin Labs Inc., Enzon Pharmaceuticals Inc., Gland Pharma Limited, Gilead Life sciences, and Lifecare Innovations Private Limited.

Order Your Copy Now (Customized report delivered as per your specific requirement)@ https://www.reportsanddata.com/checkout-form/2153

For the purpose of this report, Reports and Data has segmented the Leishmaniasis Treatment market on the basis of Disease type, pathological tests, therapy type, end-use, and region:

Disease Type (Revenue, USD Million; 2017–2027)

  • Cutaneous Leishmaniasis
    • Diffuse Cutaneous Leishmaniasis
    • Mucocutaneous Leishmaniais
  • Mucosal Leishmaniasis
  • Visceral Leishmaniasis

Pathological tests (Revenue, USD Million; 2017–2027)

  • By Serological Tests
    • Direct Agglutination Test
    • Indirect Immunofluorescent Antibody test (IFAT)
    • Enzyme Linked Immunosorbent Assay (ELISA)
    • Others
  • Parasitological Evaluation
    • Punch Biopsy
    • Bone Marrow Biopsy
    • Others
  • DNA- Based Methods
    • Nucleic Acid Hybridization
    • Polymerase Chain Reaction (PCR)
  • Immunological Methods
  • Others

 Therapy type (Revenue, USD Million; 2017–2027)

  • By Drug Therapy
    • Pentavalent Antimonials
      • Sodium Stibogluconate
      • SSG Meglumine antimoniate
    • Antifungal
    • Antibiotics
      • Amphotericin B
      • Liposomal amphotericin B
      • Miltefosine
      • Paromomycin
      • Pentamidine
    • By Non-Drug Therapy
      • Cauterization
      • Surgical Excision
      • Cryotherapy

End-Use Revenue, USD Million; 2017–2027)

  • Hospitals
  • Clinics
  • Diagnostic Laboratory
  • Others

Regional Outlook (Revenue, USD Million; 2017–2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/leishmaniasis-treatment-market

Read More Reports:-

Electrocardiogram Equipment Market Size, Share And Industry Analysis By Type (Resting ECG System, Holter Monitors, Stress ECG Monitors, and Event Monitors), By Application (Hospitals, Ambulatory Care, and Others), and By 0Region Forecast To 2028

Nasal Cannula Market By Type (Low Flow, High Flow), By Material (Plastic, Silicone) By End-use (Hospitals, Ambulatory Healthcare Services, Long Term Care Centers, Others), By Application (Cardiovascular Surgery, Oxygen Therapy, General Therapy, Plastic Surgery, Orthopedic Surgery, Others) and By Region Forecast to 2028

Dental Gypsum Market Size, Share And Industry Analysis By Type (Dental Plaster, Model Dental Stone, and Die Dental Stone), By Application (Hospital, Clinics, and Others), and By Region Forecast To 2028

Blood Pressure Monitoring Device Market Size, Share And Industry Analysis By Product Type (Aneroid BP Monitors, Digital BP Monitors, Blood Pressure Instrument Accessories, Sphygmomanometers, and Others), By End-Use (Hospitals and Clinics, Ambulatory Surgical Centers, Home Settings, and Others), and By Region Forecast to 2028

Homeopathy Product Market by Product Type (Tablets, Ointments, Biochemics, Tincture, Dilutions, Others), By Applications (Dermatology, Gastroenterology, Immunology, Neurology, Respiratory, Analgesic & Antipyretic, Others), By Source (Minerals, Animals, Plants), By End-use (Research Laboratories, E-retailers, Retailers, Hospitals, Homeopathic Clinics, Others), and By Region Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email